Conclusion: Cystatin C levels are associated with the prognosis of nasopharyngeal carcinoma patients.

Methods: Fourteen patients with nodal metastases from nasopharyngeal carcinoma were studied.

After resection of nasopharyngeal carcinoma was performed, the urinary protein level decreased rapidly.

Objective: Patients with nasopharyngeal carcinoma experience highly variable outcomes despite receiving similar therapeutic regimens.

Conclusion: VEGF plays an important role in the growth and prognosis of nasopharyngeal carcinoma.

Conclusion: Simultaneous boost irradiation radiotherapy is feasible in patients with locally advanced nasopharyngeal carcinoma.

One patient each with nasopharyngeal carcinoma and fibrous sarcoma were also treated without success.

Maxillary osteosarcomas after irradiation for nasopharyngeal carcinoma do not appear to have been described.

During this period, the patient was diagnosed with nasopharyngeal carcinoma.

These results suggest the EBV association with BC in an endemic area of nasopharyngeal carcinoma.

Methods: Quantitative Polymerase Chain Reaction was performed on nasopharyngeal carcinoma and their paired normal tissues.

We conducted skin-prick allergen tests on 22 patients with newly diagnosed but not-yet-treated nasopharyngeal carcinoma.

We aimed to compare these frameworks in nasopharyngeal carcinoma.

We report a very rare case of recurrent nasopharyngeal carcinoma with local involvement of lacrimal sac.

Background: Circulating Epstein-Barr virus DNA is a predictor of disease recurrence in patients with nasopharyngeal carcinoma.

The primary treatment for nasopharyngeal carcinoma is radiotherapy.